ADT’s entrance in the S&P SmallCap 600 Index took effect on Feb. 9, 2026, marking a significant achievement for the company. Chairman, President and CEO Jim DeVries highlighted that this recognition ...

Among men with prostate cancer receiving androgen deprivation therapy (ADT), oxybutynin led to significant reductions in hot flash frequency, with the 5-mg twice-daily dose decreasing hot flashes by ...

A phase 2 randomized, double-blind trial tested oxybutynin 2.5 mg BID and 5 mg BID versus placebo for six weeks in men on stable ADT with ≥28 weekly hot flashes. Dose-dependent efficacy was observed, ...

Study compares intermittent fasting, GLP-1 medication and nutritional counseling to reduce cardiovascular and metabolic risks from androgen deprivation therapy "ADT is a cornerstone of prostate cancer ...

Available at Boss Machinery! This Volvo A40F Dump Truck from 2012 has an engine power of 347 kW and counts 19620 operational hours. The total weight of this Volvo A40F is 30800 kg and the dimensions ...

City of Hope ®, one of the largest and most advanced cancer research and treatment organizations in the United States with its National Medical Center ranked among the nation’s top cancer centers by U ...

Volvo considering launching a full-size, three-row SUV to meet growing U.S. and Chinese demand. New plug-in hybrid SUV may be built in South Carolina, possibly named XC100. Dealers report families ...

The Sweden-based automaker on Thursday reported a sharp drop in fourth-quarter profit, citing tariffs and weak demand. Volvo Cars CEO Hakan Samuelsson told CNBC that external market conditions in 2025 ...

Pediatric-Friendly Formulations: Critical to Maximizing Benefit of Novel Therapeutics Such as Selumetinib for Children With Neurofibromatosis and Other Neoplasms The content is solely the ...

A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to treat overactive bladder symptoms, reduces hot flashes compared to the ...